Hamdullah Sozen
Istanbul University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hamdullah Sozen.
Journal of Obstetrics and Gynaecology Research | 2011
Oya Demirci; Ahmet Semih Tuğrul; Nihal Dolgun; Hamdullah Sozen; Sadiye Eren
Aim: The purpose of this study investigated the relationship between early pregnancy plasma lipid concentrations and risk of pre‐eclampsia.
Journal of Obstetrics and Gynaecology Research | 2011
Oya Demirci; Ayşegül Ünal; Elif Demirci; Hamdullah Sozen; Yesim Akdemir; Esra Boybek; Aktuğ Ertekin
Aim: To study the relationship between cervical lengths measured by ultrasound and risk of preterm delivery.
Journal of Obstetrics and Gynaecology Research | 2015
Hamdullah Sozen; Dogan Vatansever; Ahmet Cem Iyibozkurt; Samet Topuz; Mehmet Özsürmeli; Yavuz Salihoglu; Burcu Guzelbey; Sinan Berkman
The aim of the study was to describe clinicopathologic characteristics, survival outcomes and the factors associated with recurrence in patients diagnosed with synchronous primary endometrial and epithelial ovarian cancers.
International Journal of Gynecology & Obstetrics | 2011
Ozge Karaosmanoglu; Ebru Cogendez; Hamdullah Sozen; Mehmet Resit Asoglu; Yesim Akdemir; Sadiye Eren
filling the pelvis with vascularized soft tissue, thereby preventing the formation of fixed small-bowel loops in the pelvis. At the time of writing, the woman was healthy, had completed adjuvant pelvic radiotherapy, and was scheduled to start carboplatinbased chemotherapy. To conclude, en bloc resection of the rectum may enable optimal cytoreduction in womenwith rectovaginal fistula caused by recurrent ovarian cancer.
Australian & New Zealand Journal of Obstetrics & Gynaecology | 2016
Hamdullah Sozen; Rumeysa Ciftci; Dogan Vatansever; Samet Topuz; Ahmet Cem Iyibozkurt; Hamza Ugur Bozbey; Cenk Yasa; Halime Çali; Ekrem Yavuz; Seden Kucucuk; Adnan Aydiner; Yavuz Salihoglu
The aim of this study was to describe the impact of postoperative adjuvant treatment modalities and identify risk factors associated with recurrence and survival rates in women diagnosed with early stage type II endometrial cancer and carcinosarcoma.
Journal of Obstetrics and Gynaecology Research | 2015
Dogan Vatansever; Hamdullah Sozen; A. Cem Iyibozkurt; Cihan Comba; Ekrem Yavuz; Samet Topuz
Lymphangioleiomyomatosis is a very rare disease that primarily affects the lungs. The atypical smooth muscle cells in these tumors stain both with smooth muscle markers and melanocytic markers characteristically like their counterparts in other members of the PEComa family. Extrapulmonary lymphangioleiomyomatosis, especially without pulmonary involvement, is extremely rare. The clinical importance of lymphangioleiomyomatosis lies in the fact that it may mimic other malignant diseases, such as lymphoma or sarcoma. Here, we report a case of extrapulmonary lymphangioleiomyomatosis without involvement of the lungs, in a patient pre‐diagnosed as having lymphoma metastasized to the uterus or uterine sarcoma.
Applied Immunohistochemistry & Molecular Morphology | 2017
Orhun Cig Taskin; Semen Onder; Samet Topuz; Hamdullah Sozen; Fatma Sen; Ridvan Ilhan; Ekrem Yavuz
This study aimed to investigate whether a selected immunohistochemical panel (estrogen receptor, p53, ARID1A, PPP2R1A, HNF-1&bgr;) could contribute to the diagnostic process of high-grade endometrial carcinomas (HG-ECs). We also aimed to analyze the correlation of these immunohistochemical results with several morphologic variables and survival data. After revising the diagnosis of 78 HG-ECs, immunohistochemical analysis was performed for each case. After immunohistochemical analysis, a specific diagnosis of prototypic HG-EC was established in most of the cases that were uncertain due to morphologic ambiguity. In the univariate analysis, older patient age, type II morphology, undifferentiated carcinoma and carcinosarcoma type of histology, altered p53 immunostaining, strong membranous staining of PPP2R1A, presence of lymphovascular invasion in serous carcinoma, and microcystic, elongated, and fragmented-type infiltration pattern in endometrioid carcinoma were significantly related to poor prognosis. In the multivariate analysis, only older patient age and carcinosarcoma or undifferentiated/dedifferentiated carcinoma type histology were found to be significantly poor prognostic factors (P=0.011), whereas advanced FIGO stage and type II histology were found to be correlated with poor prognosis, but did not reach statistical significance. We suggest that immunohistochemistry should be used in the differential diagnosis of HG-ECs, especially those with ambiguous morphology. Markers used in this study made a valuable contribution to the diagnostic process as well as prediction of prognosis.
European Journal of Obstetrics & Gynecology and Reproductive Biology | 2011
Ateş Karateke; Yesim Akdemir; Mehmet Kucukbas; Hamdullah Sozen; Cetin Cam
eservation in ovarian lymphomas, possibly supporting the use of RH analogue during chemotherapy as a standard [4]. The case rther illustrates that cryopreservation of ovarian tissue with future -transplantation may not be safe in an ovarian Burkitt’s mphoma. However, oocyte freezing appears to be an alternative r fertility preservation if a partner is not present [1]. Because an arian Burkitt’s lymphoma is regarded as a systemic lymphoblastic sease originating in the ovaries and prognosis of these aggressive mours is excellent when adequately treated systemically, under e given circumstances removal of the contralateral ovary was not dicated in this patient [5,6]. *Corresponding author. Tel.: +49 251 8348202; fax: +49 251 8348267 E-mail address: [email protected] (A.N. Schüring). These authors contributed equally.
Journal of obstetrics and gynaecology Canada | 2018
Alpaslan Kaban; Samet Topuz; Hamdullah Sozen; Yavuz Salihoglu
OBJECTIVE The aim of the study is to investigate the effect of increasing serous component ratio on survival in endometrium cancer patients with serous plus endometrioid histology. METHODS The study cases included 33 patients who underwent surgery for endometrial cancer and had serous plus endometrioid carcinoma based on the pathology report between 2005 and 2014. Univariate Cox regression analysis was used for evaluation of the effects of age, stage, lymphadenectomy, serous component ratio, lymphovascular space invasion, depth of myometrial invasion, and tumour size criteria on disease-free survival (DFS) and overall survival (OS). RESULTS Median age was 63.0 years (range 45-81), and median follow-up duration was 54 months (range 13-144). Serous component ratio was less than 25% in 18 patients (55%) and more than 25% in 15 patients (45%). The rate of recurrence, DFS and OS were similar in the two groups (P = 0.695, P = 0.238, P = 0.134, respectively). Twenty-five patients (76%) were stage 1-2; 8 patients were (24%) stage 3-4. We evaluated the relationships of age, stage, lymphadenectomy, serous component ratio, lymphovascular invasion, myometrial invasion depth, and tumour size criteria with DFS and OS by univariate Cox regression analysis. Among these criteria, only the stage was detected to be in a significant relationship with DFS and OS (log rank test P < 0.001 and P = 0.01). CONCLUSION This study supported that the most important prognostic factor in patient with serous plus endometrioid histology is the stage of the cancer. Patients with a serous component ratio of less than 25% had similar recurrence and mortality rates to those with more than 25%.
Journal of obstetrics and gynaecology Canada | 2017
Alpaslan Kaban; Samet Topuz; Pinar Saip; Hamdullah Sozen; Yavuz Salihoglu
OBJECTIVE The aim of the study is to investigate factors related to overall survival in advanced stage ovarian, tubal, or peritoneal cancer and to identify strong and weak prognostic factors. METHODS We retrospectively reviewed 190 patients who underwent primary cytoreductive surgery between 2003 and 2013. RESULTS Median overall survival duration was founded 58 months (95% CI 49-67). Five-year overall survival ratio was 48.5%. Presence of tumour at upper abdomen, suboptimal cytoreduction (residual >1 cm), surgery without lymphadenectomy, and presence of peritoneal ascites more than 1 L had a significantly negative effect on overall survival, but not histological grade and CA-125 level, by univariate Cox analysis. Age and presence of tumour in the upper abdomen were independent poor prognostic factors according to multivariate Cox model (HR 1.025; 95% CI 1.009-1.040 and HR 1.533; 95% CI 1.039-2.263, respectively). CONCLUSION This study supports that the presence of tumour in the upper abdomen is the most important independent poor prognostic factor in patients with performed primary surgery for advanced stage ovarian, tubal, and peritoneal cancer. Upper abdominal metastasis is the most important predictive factor for optimal cytoreduction (P <0.001, HR 6.567; 95% CI 3.059-14.096).